Intervention
Re-deployment of intervention team members from the outpatient program to acute inpatient units to manage COVID-19 issues resulted in several impacts. Different IP team members (Nurse, Physical Therapist, Occupational Therapist) at one of the sites were re-deployed at various points in time during the intervention period. During those redeployments, participants had limited or no access to these IP team members resulting in different doses of the intervention being offered to participants within and across sites. Re-deployment also impacted attendance at the monthly IP team conferences within sites. The trial had to be stopped 3 months early at one site due to re-deployment of several intervention team members to manage COVID-19 issues. The result was that some participants at this site were offered fewer than 6 visits and discussed less frequently at the IP team conference. It is possible that these impacts could have reduced intervention effectiveness.Several mitigation strategies were used to address these impacts. The Care Coordinator at each of the sites conducted additional visits to cover for IP team members during redeployments. We tracked the number of visits intervention participants received and number of times they were discussed at the IP team conference to determine if there is a dose–response relationship. The IP team at the study site that stopped the intervention early agreed to offer participants more than one visit per month to make up for the shorter intervention period (e.g., accelerating intervention delivery to increase dose prior to stopping).